Register for our free email digests:
Merck KGaA
www.emdgroup.com/en
Latest From Merck KGaA
Biopharma COVID-19 Collaborations May Avoid Antitrust Hurdles, FTC And DOJ Suggest
FTC and DoJ issue guidance for businesses working together to tackle coronavirus pandemic; BIO is 'pleased' they intend to help facilitate critical partnerships.
Coronavirus Update: R&D Starts, Product Delays, Continuing Collaboration
In addition to our daily in-depth coverage of key events relating to the coronavirus pandemic, we’re bringing you a periodic round-up of other significant developments.
Coronavirus Update: More Companies Join Therapeutics Accelerator, FDA Delays AdCom For First NASH Drug
As the global number of COVID-19 cases exceeds 500,000 for the first time, more biopharma companies throw their weight behind Gates Foundation's drug-hunting initiative.
iOnctura Develops Next-Generation PI3K-Delta Inhibitors For Cancer
Emerging Company Profile: Switzerland’s iOnctura is working on PI3K-delta inhibitors and autotaxin inhibitors that have potential in solid tumors and cancer-associated fibrosis.
Company Information
- Industry
- Pharmaceuticals
- Therapeutic Areas
- Cancer
- Cardiovascular
- Gynecological, Urological
- Metabolic Disorders
- Neurology, Nervous System
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
Europe
-
Western Europe
-
Germany
-
Germany
-
Western Europe
-
Europe
- Parent & Subsidiaries
-
Merck KGaA
- Amerpharm Investments Ltd.
- Biovation Ltd.
- Center Laboratories
- Chemische Fabrik Lehrte Dr. Andreas Kossel
- Durachemie GMBH
- E. Merck Nederland
- EM Laboratories Inc
- EM Pharmaceuticals Inc.
- EMD Biosciences Inc.
- EMD Chemicals Inc.
- EMD Lexigen Research Center
- EMD Serono Inc.
- Genpharm Inc.
- Hermal Kurt Herrmann & Co.
- Hermal Pharmaceutical Laboratories Inc.
- Laboratoire Theramex
- Laboratoires Merck-Clevenot SA
- Laboratorios BOI SA
- Lipha Chemicals Inc.
- Lipha Pharmaceuticals Inc.
- Lipha SA
- Merck Eprova AG
- Merck Ethicals
- Merck HOEI
- Merck Lipha
- Merck Pharma SPA
- Merck Pty. Ltd.
- Merck SA Industrias Quimicas
- Merck Sante SAS
- Merck Serono SA
- MilliporeSigma
- NM Pharma AS
- Novagen Inc.
- VWR Canlab
- Senior Management
-
Stefan Oschmann, PhD, CEO
Marcus Kuhnert, CFO - Contact Info
-
Merck KGaA
Phone: (49) 6151 72 0
Frankfurter Str. 250
Darmstadt, MA 64293
Germany
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice